The increasing prevalence of diabetes and its complications, such as cardiovascular and
kidney disease, remains a huge burden globally. Identification of biomarkers for the …

High-density lipoproteins comprise roughly 25–30% of the circulating proteins involved in
the transport of lipids in circulation. These particles differ in size and lipid composition …

Background Pemafibrate is a novel, selective peroxisome proliferator‐activated receptor α
modulator (SPPARMα). In mice, Pemafibrate improved the histological features of non …

High-density lipoproteins (HDLs) protect against atherosclerosis by removing excess
cholesterol from macrophages through the ATP-binding cassette transporter A1 (ABCA1) …

Scavenger receptor BI (SR-BI) is the major receptor for high-density lipoprotein (HDL)
cholesterol (HDL-C). In humans, high amounts of HDL-C in plasma are associated with a …

Gut microbiota has been implicated in major diseases affecting the human population and
has also been linked to triglycerides and high-density lipoprotein levels in the circulation …

Background: The role of high-density lipoprotein (HDL) function in cardiovascular disease
represents an important emerging concept. The present study investigated whether HDL anti …

Obesity, insulin resistance, type 2 diabetes mellitus and cardiovascular disease form a
metabolic disease continuum that has seen a dramatic increase in prevalence in developed …

Liquid chromatography-mass spectrometry (LC-MS)-based lipidomics has undergone
dramatic developments over the past decade. This review focuses on state of the art in LC …

Uptake of low-density lipoprotein (LDL) particles by macrophages represents a key step in
the development of atherosclerotic plaques, leading to the foam cell formation. Chemical …